These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 722958)

  • 41. Pharmacological properties of a new anticholinergic agent, 1, 1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene) piperidinium bromide (SA-504).
    Tamaki H; Tanaka M; Murata S; Harigaya S; Kiyomoto A
    Jpn J Pharmacol; 1972 Oct; 22(5):685-99. PubMed ID: 4539786
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of glycopyrrolate on gastric secretion and terminal antral motor activity in vagally innervated and denervated gastric pouch dogs.
    Alphin RS; Droppleman DA; Ward JW
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):66-71. PubMed ID: 5093194
    [No Abstract]   [Full Text] [Related]  

  • 43. [Studies on aromtic basic ethers with antispasmodic activity. VII. Syntheses and anticholinergic activities of homologous phenyl 1-phenyl-3-piperidinopropyl ethers (author's transl)].
    Yoshida A; Morita M; Ogawa S
    Yakugaku Zasshi; 1973 Oct; 93(10):1325-30. PubMed ID: 4798508
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacology of gastric motility.
    Willems JL; Lefebvre RA; Bogaert MG
    Acta Gastroenterol Belg; 1982; 45(11-12):471-5. PubMed ID: 7186727
    [No Abstract]   [Full Text] [Related]  

  • 45. Neurogenic inhibition of duodenal and jejunal motility in the anaesthetized rat.
    Gustafsson BI; Delbro DS
    Eur J Pharmacol; 1994 May; 257(3):227-33. PubMed ID: 8088344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacodynamic study of an antispasmodic and tranquilizing combination recommended in the treatment of digestive ulcers].
    Mercier J; Dessaigne S; Gavend MR; Etzensperger P; Veran J
    Pathol Biol; 1967 Apr; 15(7):441-6. PubMed ID: 4864902
    [No Abstract]   [Full Text] [Related]  

  • 47. [A comparative study of gastric motility and secretion after stimulation by 2-deoxy-D-glucose in dogs (author's transl)].
    Boiselle JC; Rozé C; Vatier J
    Gastroenterol Clin Biol; 1977 Apr; 1(4):345-52. PubMed ID: 892309
    [No Abstract]   [Full Text] [Related]  

  • 48. [Differences in the motility of various parts of the large intestine in the dog (author's transl)].
    Stulrajter V; Brozman B; Smyková E
    Bratisl Lek Listy; 1976 Jan; 65(1):60-8. PubMed ID: 1247918
    [No Abstract]   [Full Text] [Related]  

  • 49. [Spasmolytic effect of octylonium bromide on gastrointestinal motility in vitro].
    Zappia L; Molina E; Scarpignato C; Coruzzi G; Bertaccini G
    Farmaco Prat; 1980 May; 35(5):258-64. PubMed ID: 7449945
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of cisapride on upper-gastrointestinal motility and digestive hormones].
    Abe S; Furukawa Y; Nakata K; Morita M; Ohira Y; Haneu Y; Aoki T
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):73-8. PubMed ID: 2273690
    [No Abstract]   [Full Text] [Related]  

  • 51. [Humoral control of gastrointestinal motility (author's transl)].
    Itoh Z
    Horumon To Rinsho; 1980 Oct; 28(10):1161-8. PubMed ID: 7011599
    [No Abstract]   [Full Text] [Related]  

  • 52. [Differentiation of the effects of antispasmodic agents on the electromyogram of the sphincter of Oddi and the duodenum of the alert rabbit].
    Achard F; Denavit M; Roche M
    C R Seances Soc Biol Fil; 1985; 179(4):462-70. PubMed ID: 2938675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional differences in motor responsiveness to antimuscarinic drugs in rabbit isolated small and large intestine.
    Barocelli E; Ballabeni V; Chiavarini M; Caretta A; Molina E; Impicciatore M
    Pharmacol Res; 1995 Jan; 31(1):43-8. PubMed ID: 7784305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of domperidone on gastric movement and blood flow in dog (author's transl)].
    Fujii K; Takasugi S
    Nihon Heikatsukin Gakkai Zasshi; 1980 Mar; 16(1):37-46. PubMed ID: 7277931
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of yohimbine on xylazine-induced prolongation of gastrointestinal transit in dogs.
    Hsu WH; McNeel SV
    J Am Vet Med Assoc; 1983 Aug; 183(3):297-300. PubMed ID: 6885603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical pharmacology and therapeutic results of a specific antagonist in disorders of gastroduodenal and peripheral motility].
    Bertrand J; Thillier JL
    Sem Hop; 1980 Oct 18-25; 56(39-40):1579-81. PubMed ID: 6255572
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of antispasmodic and related activity in the intact dog.
    Benoit PS; Katz NL; Mintz MR; Jenkins HJ
    J Pharm Sci; 1969 Feb; 58(2):225-8. PubMed ID: 4388580
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of trimebutine maleate on the gastrointestinal motility in conscious dogs].
    Takenaga H; Magaribuchi T; Nosaka K; Tamaki H
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):271-8. PubMed ID: 7152394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of cisapride on contractile activity of the gastrointestinal tract].
    Suzuki T; Nakaya M; Nakamura T; Itoh Z
    Nihon Heikatsukin Gakkai Zasshi; 1985 Apr; 21(2):139-49. PubMed ID: 4087620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticholinergic suppression of fetal rabbit upper gastrointestinal motility.
    Acosta R; Lee JJ; Oyachi N; Buchmiller-Crair TL; Atkinson JB; Ross MG
    J Matern Fetal Neonatal Med; 2002 Mar; 11(3):153-7. PubMed ID: 12380669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.